Trials / Completed
CompletedNCT01795625
OneTouch® Verio™Pro+ Blood Glucose Monitoring System Clinical Accuracy Study in China
A Multi-centre, Open Clinical Evaluation to Determine Professional Clinical Accuracy Comparing the OneTouch® Verio™Pro+ Blood Glucose Results With the YSI 2300 Analyzer.
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 301 (actual)
- Sponsor
- Johnson & Johnson Medical, China · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The evaluation will determine professional clinical accuracy comparing the OneTouch® Verio™Pro+ blood glucose results with the YSI 2300 analyzer. "Professional Clinical Accuracy" is defined as accuracy of the system when used by a trained healthcare professional.
Conditions
Timeline
- Start date
- 2012-08-31
- Primary completion
- 2012-10-31
- Completion
- 2012-10-31
- First posted
- 2013-02-20
- Last updated
- 2023-08-21
Locations
2 sites across 1 country: China
Source: ClinicalTrials.gov record NCT01795625. Inclusion in this directory is not an endorsement.